glp 1 approved for pediatrics all our Medicare folks 👋 — this upcoming GLP-1 Bridge Program may help make select weight-loss medications more affordable starting July 2026. 💉✨ GLP-1 receptor agonists and obesity

This article first appeared on CT Mirror and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Assessment: melanocyte activity in vitro, in vivo melanogenesis in several model organisms (Xenopus frog, lizard, mouse)

Brzoska T, Luger TA, Maaser C, Abels C, Bohm M

Peak maintenance dose at discontinuation plays a measurable role in symptom duration

Real-world evidence (Nature, 2023) A survey of 153 adults with obesity who were already taking semaglutide or tirzepatide found they reported a 73% reduction in weekly alcohol consumption, and their likelihood of binge-drinking dropped by about 80% compared to similar people not on medication